NLM Logo

DC-MelVac MeSH Supplementary Concept Data 2024


MeSH Supplementary
DC-MelVac
Unique ID
C533343
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C533343
Registry Number
0
Heading Mapped to
*Cancer Vaccines
Frequency
1
Note
a second generation melanoma vaccine (DC-Melvac) that consists of five human melanoma cell lines, a recombinant vaccinia virus that encodes for IL-2, as well as dendritic cells that have been programmed to recognize certain melanoma associated antigens; approved by FDA in Phase I clinical trials 2/2008
Source
G Ital Dermatol Venereol 2008 Feb;143(1):59-70
Date of Entry
2008/12/03
DC-MelVac Preferred
page delivered in 0.005s